JPMorgan Chase & Co’s Global Blood Therapeutics, Inc. GBT Stock Holding History

JPMorgan Chase & Co’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,304,636	Closed	-$157M	–	6304
2022 Q3	$157M	Buy	2,304,636 +1,898,523	+467%	+$129M	0.02%	530
2022 Q2	$13M	Buy	406,113 +220,883	+119%	+$7.06M	﹤0.01%	1712
2022 Q1	$6.42M	Buy	185,230 +14,774	+9%	+$512K	﹤0.01%	2375
2021 Q4	$4.99M	Buy	170,456 +117,734	+223%	+$3.45M	﹤0.01%	2583
2021 Q3	$1.34M	Sell	52,722 -5,197	-9%	-$132K	﹤0.01%	3427
2021 Q2	$2.03M	Sell	57,919 -690,704	-92%	-$24.2M	﹤0.01%	3212
2021 Q1	$30.5M	Buy	748,623 +43,678	+6%	+$1.78M	﹤0.01%	1312
2020 Q4	$30.5M	Buy	704,945 +48,510	+7%	+$2.1M	﹤0.01%	1186
2020 Q3	$35.4M	Sell	656,435 -85,599	-12%	-$4.62M	0.01%	1034
2020 Q2	$46.8M	Buy	742,034 +281,651	+61%	+$17.8M	0.01%	854
2020 Q1	$23.5M	Buy	460,383 +25,693	+6%	+$1.31M	0.01%	1050
2019 Q4	$34.6M	Buy	434,690 +3,895	+0.9%	+$310K	0.01%	1041
2019 Q3	$20.9M	Buy	430,795 +30,329	+8%	+$1.47M	﹤0.01%	1337
2019 Q2	$21.6M	Buy	400,466 +18,397	+5%	+$993K	﹤0.01%	1318
2019 Q1	$20.2M	Buy	382,069 +10,621	+3%	+$562K	﹤0.01%	1331
2018 Q4	$15.2M	Buy	371,448 +9,583	+3%	+$393K	﹤0.01%	1428
2018 Q3	$13.8M	Buy	361,865 +48,188	+15%	+$1.83M	﹤0.01%	1649
2018 Q2	$14.2M	Buy	313,677 +202,027	+181%	+$9.13M	﹤0.01%	1614
2018 Q1	$5.39M	Sell	111,650 -112,229	-50%	-$5.42M	﹤0.01%	2167
2017 Q4	$8.81M	Sell	223,879 -8,742	-4%	-$344K	﹤0.01%	1895
2017 Q3	$6.86M	Sell	232,621 -3,054	-1%	-$90.1K	﹤0.01%	1986
2017 Q2	$6.45M	Buy	235,675 +11,468	+5%	+$314K	﹤0.01%	1987
2017 Q1	$8.26M	Buy	224,207 +48,382	+28%	+$1.78M	﹤0.01%	1793
2016 Q4	$2.54M	Sell	175,825 -9,480	-5%	-$137K	﹤0.01%	2534
2016 Q3	$4.27M	Buy	185,305 +8,450	+5%	+$195K	﹤0.01%	2101
2016 Q2	$2.94M	Sell	176,855 -9,145	-5%	-$152K	﹤0.01%	2272
2016 Q1	$2.95M	Sell	186,000 -1,500	-0.8%	-$23.8K	﹤0.01%	2218
2015 Q4	$6.06M	Sell	187,500 -26,075	-12%	-$843K	﹤0.01%	1844
2015 Q3	$9.01M	Buy	+213,575	New	+$9.01M	﹤0.01%	1641